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Accumulation in immunosuppressed patients of hepatitis B virus (HBV) with a deletion in the C gene is associated with
severe liver disease. The aim of this study was to determine the phenotype of such genomes in vitro. Four C gene fragments
with different types of deletions were inserted in the context of a wild-type genome and tested by transfection into HuH7
cells. The deletions did not influence mRNA and surface protein levels. Truncated C gene translation products were
expressed only from variants with in-frame deletions, whereas full-length polymerase was expressed from all variants at a
similar or higher level than in wild-type virus. None of the variants was competent for autonomous replication; however, they
produced 2- to 4.5-fold more progeny DNA than wild-type HBV when sufficiently complemented with wild-type core protein.
Similarly, when variant and wild-type DNA were cotransfected in different ratios, the variants produced 2- to 5-fold more
progeny DNA relative to the wild-type; this enrichment required the expression of the viral polymerase in cis. The mechanism
of enrichment depended on the percentage of variant in the transfected DNA mixture. When the transfected DNA contained
a small percentage of variant, enhanced replication of the variant accompanied by no or little suppression of wild-type
replication was seen. Accordingly, overall production of progeny virus was slightly increased. At a high percentage of variant
DNA, replication of both variant and wild-type decreased, probably due to a shortage of wild-type core protein. In conclusion,
emergence of C gene deletion variants in vivo may be due to enhanced replication mediated at the level of encapsidation or
reverse transcription. If the variants constitute a small part of the ccc DNA, they can be fully trans-complemented by wild-type
virus which may increase the overall virus production. © 2000 Academic PressINTRODUCTION
Hepatitis B virus (HBV) variants are found in patients
with acute and chronic infection. Many variants are pre-
dominantly seen in particular stages of chronic infection
(Gu¨nther et al., 1999). Those with large deletions in the
middle of the nucleocapsid gene (C gene deletion vari-
ants) seem to emerge in the early phase of chronic
infection, characterized by the presence of hepatitis B e
antigen (HBeAg) in serum and normal alanine amino-
transferase levels (Okamoto et al., 1987; Tsubota et al.,
1998). But they are likely to persist only temporarily. Their
presence in the circulation was found to predict sero-
conversion from HBeAg to the corresponding antibody
(anti-HBe) in the near future and, following this event, the
variants frequently disappear from circulation (Wakita et
al., 1991; Marinos et al., 1996). According to these longi-
tudinal data, C gene deletion variants were often dem-
onstrated in HBeAg-positive patients (Ackrill et al., 1993;
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286Fiordalisi et al., 1994; Uchida et al., 1994; Akarca and Lok,
1995; Okumura et al., 1996; Zoulim et al., 1996) but rarely
in those who were negative for HBeAg (Takayanagi et al.,
1993; Horikita et al., 1994; Nakayama et al., 1995). The
variants were found in few patients with hepatocellular
carcinoma (Hosono et al., 1995). Emergence and accu-
mulation of C gene deletion variants was also observed
in HBeAg-positive renal transplant recipients after long-
term immunosuppression (Gu¨nther et al., 1996a). In con-
trast to the natural course of infection, persistence of the
variants in these transplant patients was associated with
the development of end-stage liver disease and death of
patients from liver disease (Gu¨nther et al., 1996a).
All C gene deletion variants tested in vitro so far were
found to be defective for autonomous replication (Oka-
moto et al., 1993; Yuan et al., 1998b). In these studies
genome replication was rescued when nondeleted (re-
ferred to as wild-type) core protein was supplied in trans
(Yuan et al., 1998b). Quantitative analysis of the replica-
tion level and its dependence on the amount of supplied
wild-type core protein was not performed. Cotransfection
of wild-type HBV genomes with viruses containing the C
gene deletion resulted in a strong suppression of wild-
type HBV replication and an enrichment of progeny virus
with deletions in the C gene (Yuan et al., 1998a). This
phenotype led the authors to conclude that HBV with
287HBV C GENE DELETION VARIANTSdeletions in the C gene behaves like defective interfering
particles similar to that observed in other virus-cell sys-
tems. However, it is not clear from this study whether this
phenotype was due to the deletions in the C gene alone
as all tested variants also contained mutations in the
core promoter previously shown to enhance replication
(Buckwold et al., 1996). Furthermore, unlike what was
expected from this study, accumulation of C gene dele-
tion variants in patients appears not to be associated
with decreased viremia (Wakita et al., 1991; Gu¨nther et
al., 1996a; Tsubota et al., 1998). Therefore, we hypothe-
sized that the phenotype of these variants might be more
complex than described and analyzed a representative
set of C gene deletion variants without promoter muta-
tions under various conditions in cell culture. It is dem-
onstrated here that the C gene deletion variants can
replicate at higher levels compared to HBV without a
deletion in the C gene, when complemented in trans with
the appropriate level of wild-type core protein or wild-
type virus. We also show that the C gene deletion vari-
ants express similar or higher levels of polymerase pro-
tein as wild-type virus and are enriched when corepli-
cating with wild-type virus. Enrichment of the deletion
variants appears to depend on both enhanced replica-
tion and suppression of the wild-type virus depending on
the percentage of cotransfected wild-type virus, indicat-
ing that takeover of C gene deletion mutants in vivo is
more complex than previously speculated.
RESULTS
Cloning and characterization of C genes with
deletions and construction of hybrid genomes for
phenotypic analysis
HBV DNA was isolated from the serum of four previ-
ously described patients (Gu¨nther et al., 1996a; Marinos
et al., 1996) and the C gene was amplified by PCR. C
gene deletion variants in all four patients represented a
major virus population as indicated by the substantial
fraction of amplified fragments which were shorter than
wild-type length (Fig. 1A). Cloning and sequencing of
several amplified C genes revealed that patients I, D, G,
and FT were infected by HBV with a deletion of 90, 24,
120, and 144 nucleotides in the C gene, respectively.
Clones with the 144-nucleotide deletion had additionally
a TGG 3 TAG change in codon 28 of the pre-C region
preventing HBeAg expression and an insertion of a singe
T residue after position 1950. For testing the functional
consequences of C gene deletions, a mutant C gene
fragment of each patient was inserted into the context of
a wild-type genome by fragment exchange, which re-
sulted in hybrid genomes DC-90, DC-24, DC-120, and
DC-144 (Fig. 1B). Constructs DC-90 and DC-24 with in-
frame deletions may express core protein and HBeAg
with an internal deletion, while DC-120 and DC-144 can
only express short N terminal core peptides, because ofupstream insertions. The deletions in DC-90, DC-24, and
DC-120 do not affect the polymerase gene, whereas the
deletion in DC-144 removes the authentic polymerase
start codon and fuses the polymerase gene with an
FIG. 1. (A) The C gene of HBV from serum of four patients was
amplified and separated in 2% agarose gel (C, wild-type C gene; DC, C
gene with deletion). The number of deleted nucleotides as determined
by sequencing is shown below the gel. (B) Schematic presentation of
the C gene and the overlapping P gene of deletion variants and control
virus used in the study. The restriction sites used for exchange of the
mutated fragments with the corresponding C gene fragment of pHBV-
SapI are indicated at the top. Deletions are shown as open boxes with
the number of deleted nucleotides within the boxes and the position of
the deleted sequence above the boxes. Single nucleotide deletions (2)
and insertions (1) are indicated by arrows. Predicted translation prod-
ucts starting at the pre-C-ATG (position 1814), the C-ATG (position 1901),
the P-ATG (position 2307), and the J-ATG (position 2163, for DC-144 and
DC-144pol2) are indicated by large arrows below each construct.upstream located ATG, designated previously J-ATG (po-
sition 2163–2165) (Fouillot et al., 1993).
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288 GU¨NTHER ET AL.Four control genomes were used for phenotypic anal-
ysis (Fig. 1B). The genotype D wild-type genome (WT-b)
used for construction of all hybrid genomes was chosen
as the main reference in all experiments. The WT-a
hybrid genome was constructed to test whether geno-
type-A-specific mutations, as present in the C gene of
DC-90, DC-24, and DC-120, influence the phenotype.
Hybrid genome WT-core2 served as a control to test
hether a defect in core protein production is important
or the phenotype of the deletion variants. It encodes
-terminal core and HBe peptides identical to those
ncoded by DC-120, but does not contain a large dele-
tion in the C gene. Control genome DC-144pol2 is iden-
tical to DC-144, but cannot express polymerase due to an
artificial frameshift mutation in the amino terminal end of
the P gene. It was constructed in order to study whether
the expression of polymerase in cis is essential for the
phenotype of the deletion mutants.
All genomes were cloned as monomers. For functional
testing, the genomes were released from the plasmid by
SapI digestion and transfected into HuH7 cells (Gu¨nther
et al., 1995). This method has been successfully used for
phenotypic characterization of various types of HBV
variants (Gu¨nther et al., 1996b, 1998; Sterneck et al.,
1998a,b).
Viral mRNA levels
The HBV RNA levels were analyzed by Northern blot of
total cellular RNA. Hybridization of actin mRNA served as
a control for the amount of RNA loaded onto the blot. A
FIG. 2. (A) RNA blot analysis of the major HBV transcripts and actin
RNA as a control. (B) Quantitative evaluation of the pre-C/C RNA levels
(filled bar), the ratio of the pre-C/C to pre-S/S RNA levels (shaded bar),
and the actin RNA levels (open bar) as determined in two transfection
experiments (mean and standard deviation).representative blot is shown in Fig. 2A, and the quanti-
tative analysis of two independent experiments is shown 9in Fig. 2B. All major HBV RNA species were produced in
similar amounts from the deletion variants and the con-
trol genomes. As expected, the 3.5-kb pre-C/C gene
transcripts of the deletion mutants were slightly shorter
due to the deletion. There was also no difference in the
ratio of pre-C/C gene to pre-S/S gene transcripts. These
data suggest that the deletions in the C gene do not
interfere with transcription or the half-life of the major
viral RNAs.
Protein expression
Corresponding to the unchanged level of pre-S/S
mRNA, all genomes produced similar amounts of pre-S1
and pre-S2 protein, as detected by immunoblot analysis
of total cellular lysate (Fig. 3A), and secreted similar
amounts of hepatitis B s antigen (HBsAg) into the cell
culture supernatant, as measured by enzyme immuno-
assay (Fig. 3B). Since the deletions in the C gene did not
affect the synthesis of surface RNA and protein, the
surface protein level was used as an internal standard
for quantification of other virus products in subsequent
experiments.
Proteins expressed from the C gene were detected for
both variants—DC-90 and DC-24—with in-frame dele-
tion. A high level of HBeAg was measured by enzyme
immunoassay in the cell culture supernatant of DC-24-
transfected cells, whereas a level close to background
was found for DC-90 (Fig. 4A). As expected, HBeAg was
not detected for DC-120, DC-144, and WT-core2, which
FIG. 3. (A) Immunoblot analysis of pre-S1/2 proteins. (B) HBsAg
levels in the supernatant as detected by commercial enzyme immuno-
assay (mean and standard deviation; black bars, variants transfected
alone, n 5 5; shaded bars, variants cotransfected with pCMV core, n 5
; open bars, variants cotransfected with WT-b, n 5 6).
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289HBV C GENE DELETION VARIANTScannot express HBeAg. Consistent with the immunoas-
say data, DC-90 and DC-24 expressed shortened C gene
ranslation products as detected by immunoblotting of
hole cell lysate using an antibody that was raised
gainst denatured core protein and recognizes several
inear epitopes scattered over the core protein sequence
Bichko et al., 1993) (Fig. 4B). The upper and lower bands
re likely to correspond to core and HBe protein, respec-
ively, with internal deletion. However, compared to the
ore protein of both wild-type constructs, the putative
ore protein of DC-90 and DC-24 was clearly less well
etectable. Taking into consideration that most of the
pitopes recognized by the antibody are present on the
hortened core protein species, the data suggest that
he internal deletions strongly reduce the steady-state
evel of the protein.
As tested by immunoblot analysis of whole cell lysate,
ll deletion mutants expressed a full-length polymerase
FIG. 4. (A) HBeAg levels in the supernatant as detected by commer-
cial enzyme immunoassay (mean and standard deviation, n 5 10).
Differences between the HBe amino acid sequence of WT-a and WT-b
probably led to reduced secretion and/or antigenicity of WT-a. (B)
Immunoblot analysis of pre-C/C gene translation products. The position
of core protein of wild-type length is indicated. The arrows indicate the
position of a double band which is faint in the large image but clearly
visible in the inlet with enhanced contrast. (C) Immunoblot analysis of
polymerase. The position of polymerase is indicated. Positive control,
cells transfected with a polymerase expression plasmid.rotein (Fig. 4C) even if the authentic start codon was
eplaced as in DC-144. No obvious changes in the poly-
p
perase steady-state level were observed for variants
ith deletions upstream of P-ATG, whereas the polymer-
se signal of DC-144 was clearly stronger compared with
hat of the wild-type genomes. Quantitative evaluation of
wo separate blots revealed consistently a threefold in-
rease that was also evident when the pre-S1/2 protein
evel measured on the same blots was used for stan-
ardization of the polymerase values of DC-144.
eplication capacity of C gene deletion variants upon
omplementation with wild-type core protein
HBV genomes were transfected into HuH7 cells and
ore particle-associated progeny HBV DNA was isolated
rom cytoplasm and cell culture supernatant and sub-
ected to Southern blot analysis. All deletion variants as
ell as WT-core2 were not competent for autonomous
replication (Fig. 5A, left). Their replication was rescued
upon cotransfection of a plasmid expressing wild-type
core protein under CMV promoter control (Fig. 5A, middle
and right). The replication level of the variants depended
on the amount of core protein supplied in trans. The
addition of 0.4 mg of core protein expression plasmid per
1 mg of HBV DNA resulted in progeny DNA levels similar
to or slightly above that of WT-b (Fig. 5B). Increasing the
amount of expression plasmid to 1.33 mg per 1 mg of
transfected HBV DNA increased the replication level of
the deletion variants about 2-fold compared to WT-b.
Quantitative evaluation of the signals of four transfection
experiments revealed that the deletion variants pro-
duced 2- to 4.5-fold more intracellular replicative inter-
mediates and 1.8- to 2.8-fold more extracellular HBV DNA
than WT-b and WT-core2 (Fig. 5B). When compared with
T-a, the factors were even higher. Note that WT-a and
T-b have a higher intracellular level of wild-type core
rotein available than the variants, as both were also
otransfected with the same amount of expression plas-
id. Taken together, the C gene deletion variants were
ot competent for autonomous replication, but replicated
ore than wild-type HBV when complemented with suf-
icient amounts of wild-type core protein. The enhanced
eplication of the variants is specifically due to the dele-
ion in the core gene rather than to the defect in core
rotein expression, as is evident from the normal repli-
ation level of WT-core2 complemented with wild-type
ore protein.
nrichment of deletion variants after cotransfection of
ariant and wild-type DNA
Because the deletion variants replicated more effi-
iently than wild-type HBV upon complementation with
ore protein, we tested whether they can overgrow wild-
ype virus. To this end, both virus DNAs were cotrans-
ected into cells and the ratio of variant to wild-type
rogeny DNA in cytoplasm and supernatant was com-
ared with the ratio of variant to wild-type template DNA
2290 GU¨NTHER ET AL.FIG. 5. (A) Representative Southern blot analysis of particle-associated replicative HBV DNA produced by variants and controls with or without
cotransfected pCMV core. The marker contains a 3.2-kb double-stranded (ds) and a 3.2-kb single-stranded (ss) fragment. The positions of these
fragments as well as of open circular HBV DNA (oc) are indicated at the right. On the left, signals at the double-strand position represent input HBV
DNA. Note that the ss HBV DNA runs in some lanes at different positions due to variation of salt concentrations in individual samples. (B) Level of
replicative HBV DNA standardized with the corresponding HBsAg values (mean and standard deviation; black bar, 5 mg variant cotransfected withmg pCMV core, n 5 2; shaded bar, 3 mg variant cotransfected with 4 mg pCMV core, n 5 4). Top, replicative DNA level in cytoplasm; bottom,
replicative DNA level in supernatant.
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291HBV C GENE DELETION VARIANTSin the nucleus. A higher variant/wild-type ratio in the
progeny DNA than in the nuclear DNA indicates more
efficient replication of the variant relative to wild-type,
which is designated here as “enrichment.” The assay to
measure these ratios is based on competitive coampli-
fication of variant and wild-type DNA followed by quan-
FIG. 6. (A) Schematic presentation of the assay for measurement of e
the fluorescence dye by an asterisk, the internal TaqI marker mutation
y an open box. (B) Representative polyacrylamide gel analysis of the d
c), and supernatant (s) following 50%/50% cotransfection of variant an
ontrols; WT-b, position of the cleaved PCR products of WT-b. (C) En
etermined with the assay for different percentages of variant or contro
eterminations.titative restriction fragment length polymorphism (RFLP)
analysis (Fig. 6A). In detail, after cotransfection of adeletion variant or control virus with WT-b, HBV DNA was
purified from nucleus, cytoplasm, and supernatant and
amplified by PCR. A problem with PCR analysis of HBV
DNA produced following transfection is contamination of
the DNA preparation with input DNA (for an example of
such contamination see Fig. 5A, left). In this respect, the
ent of C gene deletion variants. Primers are indicated by small arrows,
ack dot, the control TaqI site by an open dot, and the C gene deletion
led PCR products amplified with HBV DNA from nucleus (n), cytoplasm
. variant/control, position of the cleaved PCR products of variants and
t factor in cytoplasm (black bars) and supernatant (shaded bars) as
transfected DNA mixture. Mean and standard deviation of at least twonrichm
by a bl
ye-labe
d WT-b
richmenuse of linear monomeric HBV genomes for transfection is
of great advantage. An appropriate primer design can
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292 GU¨NTHER ET AL.prevent amplification of input DNA unless it is converted
into replication-competent templates in the nucleus,
which is not possible if plasmid-integrated overlength
HBV genomes are used for transfection. Therefore, the
primers chosen for PCR encompass a region which is
not contiguous on the transfected linear DNA, namely
the nick region of the HBV genome. Furthermore, the
deletions in the C gene are not located within the am-
plicons to prevent preferential amplification of the variant
DNA. The amplicons of the deletion variants and controls
were distinguished from those of WT-b by RFLP analysis
using TaqI enzyme. A corresponding site is unique in
WT-b amplicons (position 1909) but absent from ampli-
cons of variants and controls. As an internal control for
cleavage, a second TaqI site was engineered at the 59
end of one PCR primer followed by a heterologous tail of
15 nucleotides. Failure of the cleavage assay would
result in incomplete removal of this short sequence from
the PCR products. Following TaqI cleavage, the PCR
products were subjected to denaturing polyacrylamide
gel electrophoresis to separate fragments which re-
mained uncleaved, those of the variants which were
cleaved only at the control site, and those of WT-b which
were cleaved both at the control and at the internal sites
(positions uncleaved, variant/control, and WT-b, respec-
tively, in Fig. 6B). The fragments were detected and
quantified via a fluorescence dye coupled to one of the
PCR primers. In all assays that were performed, no
fragments at the uncleaved position remained (as an
example, see Fig. 6B) indicating that all available TaqI
sites were cleaved. The variant/WT-b signal ratio in the
nucleus, cytoplasm, and supernatant was determined
and the enrichment factor was calculated as described
under Materials and Methods.
Three sets of cotransfection experiments were per-
formed to test the enrichment of the variants. Mixtures of
20% variant or control with 80% WT-b DNA, mixtures of
50% variant or control with 50% WT-b DNA, and mixtures
of 66% variant or control with 33% WT-b DNA were
transfected. In all three sets of experiments, the variants
became enriched 1.5- to 5.1-fold in the cytoplasm and 1.8-
to 5.3-fold in the supernatant (Fig. 6C). Consistent with
the core protein complementation experiments, no en-
richment was seen for WT-a and WT-core2. The enrich-
ment factors for the deletion variants correlated fairly
well with their replication level observed upon supply of
wild-type core protein by pCMV core in the order DC-
90 , DC-24 , DC-120 , DC-144, suggesting that both
effects are linked. In contrast to DC-144, the control
variant DC-144pol2, which is identical to variant DC-144
ut does not express polymerase, was completely over-
rown by WT-b (Fig. 6B, lane DC-144pol2). The extremely
weak PCR signal for DC-144pol2 DNA in cytoplasm and
upernatant confirms the highly cis-preferential packag-ng of pregenomic RNA by the HBV polymerase (Barten-
chlager et al., 1990). In addition, it shows that there is no
w
tontamination of the cytoplasmic preparation by nuclear
omponents and no contribution of linear input DNA to
he PCR signal. In conclusion, consistent with the core
rotein complementation analysis, C gene deletion vari-
nts produce more progeny DNA than wild-type HBV
hen both viruses coreplicate. This effect is independent
f the percentage of variant in the transfected DNA
ixture. A defect in core protein synthesis is not impor-
ant for enrichment as revealed by analysis of WT-core2,
whereas expression of polymerase in cis is essential.
Overall and proportionate progeny DNA synthesis
after cotransfection of variant and wild-type DNA
The enhanced replication of the variants may lead to
an increased overall production of progeny virus after
cotransfection of variants and WT-b, provided that WT-b
produces sufficient core protein and there is no major
inhibitory effect of the variants on wild-type replication. In
order to test this hypothesis, progeny virus DNA in cyto-
plasm and supernatant that was produced following co-
transfection of variant with WT-b was subjected to South-
ern blot analysis (Fig. 7A). The signals were quantified
and the progeny DNA level—relative to that obtained
with WT-b alone—was plotted versus the percentage of
variant DNA in the cotransfected mixture. (Fig. 7B, top;
data of the transfection of 100% variant or control shown
in Fig. 5A, left, were also included). The resulting curves
revealed a small increase in progeny DNA synthesis
when the transfected DNA mixture contained 20 and/or
50% deletion variant, while no clear effects were ob-
served with the control genomes WT-a and WT-core2.
lthough this increase is close to the difference that can
eliably be detected in transfection assays, several facts
rgue for a biological effect. The increased virus produc-
ion was observed with all four variants, was demon-
trated in cytoplasm and supernatant, and was repro-
uced in several experiments. In addition, the strongest
ffect was observed with DC-144 which also showed the
ighest level of replication upon complementation with
ore protein. Altogether, these data indicate that a nu-
lear HBV DNA pool containing 20 to 50% C gene dele-
ion variant produces slightly more progeny virus than a
orresponding amount of DNA consisting only of wild-
ype HBV DNA.
The above experiments raised the question of whether
he enrichment of C gene deletion variants and the in-
rease of overall DNA synthesis result only from en-
anced replication of the variants, or whether changes of
he WT-b replication level play an additional role. To
ddress this question, the proportionate progeny DNA
evel of variant and WT-b was calculated using the ex-
erimentally determined enrichment factor and the cor-
esponding level of overall DNA synthesis. The values
ere plotted versus the percentage of variant DNA in the
ransfected DNA mixture. The resulting curves revealed
293HBV C GENE DELETION VARIANTSthat all deletion variants produced a high level of prog-
eny DNA (up to 1.3) even when their proportion in the
transfection mixture was only 20 or 50% (Fig. 7B, bottom).
Note that WT-b produces a progeny DNA level of 1.0
when it accounts for 100% of the transfected DNA. On the
other hand, the synthesis of progeny WT-b DNA corre-
lated roughly with the proportion of WT-b in the trans-
fected DNA in these experiments (Fig. 7B, bottom). This
indicates enhanced replication of the variants and
largely unchanged replication of wild-type when the
transfected DNA mixture contained 20 or 50% variant. To
express this quantitatively, the progeny DNA level was
set into a relation with the corresponding amount of
transfected DNA. This revealed that the variants pro-
duced 1.5- to 5-fold more progeny DNA relative to the
amount of transfected DNA, whereas the synthesis of
progeny WT-b DNA corresponded to or was slightly re-
duced relative to the amount of transfected WT-b DNA
(Fig. 7C, left and middle). The situation was different
when 66% variant and 33% WT-b DNA were transfected
(Fig. 7C, right). Here, the variants produced only margin-
ally more progeny DNA, whereas the synthesis of prog-
eny WT-b DNA was clearly reduced relative to the
amount of transfected DNA. No considerable effects
were seen with control constructs WT-core2 and WT-a.
Altogether, these data indicate that at a low percentage
of deletion variant in the nucleus, there is no or little
interference between variant and wild-type; both repli-
cate similarly as seen after complementation with suffi-
cient amounts of core protein by pCMVcore. Accordingly,
the slightly increased overall synthesis of progeny DNA
and the enrichment of the variants are mainly the result
of the variant’s enhanced replication. When the percent-
age of variant DNA in the transfection mixture is high, the
replication of both viruses is submaximal. Under these
conditions, suppression of WT-b replication contributes
to enrichment of the variants.
DISCUSSION
In this study the phenotype of HBV with deletions in
the C gene and its interaction with wild-type HBV are
described. A representative set of mutant C genes, de-
rived from major virus populations of four patients, was
analyzed in the context of a wild-type genome by trans-
fection into HuH7 cells. The deletions in the C gene
significantly altered neither virus RNA synthesis nor the
expression of surface proteins. Shortened forms of C
gene translation products were expressed by variants
with in-frame deletions, whereas full-length HBV poly-
merase was expressed by all variants even if the authen-
tic P gene start codon was removed. Although none of
the variants was competent for autonomous replication,
they showed enhanced replication when supplied with
sufficient amounts of wild-type core protein in trans.
Similarly, upon cotransfection with wild-type HBV thevariants became enriched independent of the percent-
age of cotransfected variant. The enrichment of progeny
DNA of the variants is a complex phenomenon. At a low
percentage of cotransfected variant it resulted mainly
from enhanced replication of the variant, whereas at a
high percentage suppression of wild-type replication
contributed to enrichment. When the transfected DNA
contained 20 or 50% variant, its enhanced replication
also led to a small increase of the total progeny virus
production.
Previous attempts to detect C gene translation prod-
ucts of variants with in-frame deletions in the C gene
were not successful (Yuan et al., 1998b). By using an
antiserum recognizing several epitopes on denatured
core protein (Bichko et al., 1993), shortened species of C
gene translation products could be demonstrated in our
study. In agreement with a previous study, which sug-
gested that core protein with internal deletions is unsta-
ble (Yuan et al., 1998b), the putative core protein, espe-
cially that of DC-24, was hardly detectable. However,
unlike that reported for other C gene deletion variants
(Yuan et al., 1998b), the level of HBeAg secreted by
DC-24 was not reduced, indicating that the stability of
HBeAg was not affected and that C gene deletion vari-
ants are not generally negative for HBeAg. Altogether,
these results argue for the existence of protein se-
quences removed in DC-24 which are important for sta-
bility of cytoplasmic core protein, but not necessarily for
stability of HBeAg, which is secreted via the endoplas-
mic reticulum. These sequences may either increase
protein stability directly or facilitate assembly of core
protein into stable particles. Instability of core protein
and/or inability to form core particles are also likely
reasons why HBV with in-frame deletions in the C
gene—even if only eight amino acids are removed as in
DC-24—is not competent for autonomous replication.
Variant DC-144 is an interesting example as in this
variant the authentic polymerase start codon was re-
moved and the so-called J-ATG was fused with the P
gene. The expression of a full-length polymerase indi-
cates that the J-ATG is actually used for translation. In
addition, DC-144 seems to express more polymerase
than wild-type HBV. Since the level of pre-C/C mRNA was
not increased, it is probably the use of the J-ATG that
leads to enhanced translation efficiency. This specula-
tion is supported by two major arguments: first, com-
pared with the authentic P-ATG, the J-ATG is in a context
that predicts more efficient translation initiation by eu-
karyotic ribosomes (Kozak, 1986). Second, the translation
of the polymerase, which is thought to occur via ribo-
somal scanning on the pregenomic RNA, is hampered in
wild-type HBV by the upstream J-ATG (Fouillot et al.,
1993). This translational downregulation cannot be func-
tional in DC-144 as the J-ATG is used for polymerase
expression.
An interesting question that arises from this study is
294 GU¨NTHER ET AL.
n295HBV C GENE DELETION VARIANTShow deletions in the C gene eventually mediate en-
hanced replication and enrichment. The RNA data indi-
cate that these effects are not due to enhanced tran-
scription or stability of the pregenomic RNA. Therefore,
the phenotype of the variants is likely to result from
enhanced pregenome encapsidation or reverse tran-
scription. It is conceivable that the affinity of the deleted
pregenomic RNA to polymerase or core protein is in-
creased. Alternatively, or in addition, the encapsidation
may be increased because polymerase is more effi-
ciently translated from the deleted pregenomic RNA, or
the deletion in the encapsidated RNA facilitates the con-
version into minus-strand DNA. Since RNA encapsida-
tion and, thus, reverse transcription by the polymerase is
highly cis-preferential (Bartenschlager et al., 1990), these
conclusions are also consistent with the importance of
polymerase expression in cis for the phenotype. In-
creased translation of polymerase due to the use of the
J-ATG is likely to contribute to the phenotype in variant
DC-144. Provided that the removal of specific sequences
mediates the phenotype of DC-24, DC-90, and DC-120,
these sequences are probably located within positions
2165–2177, the common overlap of the three deletions.
The characteristic replication curves observed when C
gene deletion variants and wild-type were cotransfected
can be explained straightforwardly if one assumes an
excess production of core protein by wild-type HBV. The
question of how much core protein is produced by wild-
type virus in relation to pregenomic RNA and polymerase
has not yet been directly addressed. However, immuno-
histological and electronmicroscopical data of infected
hepatocytes argue for an excess production of core
protein. In some chronic HBV carriers as well as in
HBV-transgenic mice that replicate the virus, the nucleus
contains large amounts of core protein devoid of viral
nucleic acids (Farza et al., 1988; Phillips et al., 1992;
Guidotti et al., 1995). Since in transgenic mice virus
particles cannot enter the cell, this core protein is ap-
parently produced in excess within the cell and is not
required for synthesis of new virus. Therefore, it is likely
that wild-type HBV also produces in HuH7 cells an ex-
cess of core protein which is sufficient for maximal
replication of C gene deletion variant and wild-type virus,
at least when the percentage of variant in the nuclear
DNA pool is low, a condition which may be referred to as
“noncompetitive” coreplication. Under this condition the
FIG. 7. (A) Representative Southern blot analysis of particle-associate
in different ratios. The marker contains a 3.2-kb double-stranded (ds) a
are indicated at the right. Note that the ss HBV DNA runs in some lan
samples. (B) Level of progeny HBV DNA in cytoplasm (solid line) and s
The levels were standardized with the corresponding HBsAg values and
overall production of progeny DNA as determined by Southern blot (me
5 2, 100% variant, n 5 1). Bottom: progeny DNA synthesized proporti
and the corresponding enrichment factor as described under Materials and M
and WT-b in relation to the corresponding amount of transfected DNA (blackvariant produces more progeny DNA, as observed after
supply of sufficient core protein by expression plasmid.
As there is no or little concomitant suppression of wild-
type replication, enrichment of the variants and the small
increase in total virus production result mainly from the
enhanced replication of the variants. This explains why
the factors for enrichment and enhanced replication are
very similar for each variant. When the percentage of
deletion variant in the nuclear DNA pool increases above
a certain threshold, the produced wild-type core protein
is no longer sufficient for maximal replication of both
viruses. Under these conditions both viruses compete for
the limited amount of core protein which may be referred
to as “competitive” coreplication. The overall virus pro-
duction now decreases in parallel with the decreasing
percentage of wild-type virus and, thus, amount of intra-
cellular core protein. Although the shortage in core pro-
tein inhibits the progeny DNA production of both viruses
compared with the noncompetitive phase (Fig. 7C), the
variant still becomes enriched, probably because its pre-
genomic RNA is more efficiently encapsidated or reverse
transcribed. In conclusion, the variants can replicate
more efficiently than wild-type virus without significantly
inhibiting its replication. However, if they constitute a
large proportion of the virus population, wild-type virus
replication appears to be indirectly suppressed due to
core protein shortage.
The in vitro data have implications for understanding
the selection and counterselection processes of C gene
deletion variants in vivo. Because enrichment was inde-
pendent of the percentage of variants in the nuclear DNA
pool, one should expect that C gene deletion variants,
once they appear in the virus population of a patient,
almost completely replace wild-type HBV after multiple
rounds of infection which would lead to a strong de-
crease in overall virus production. In contrast to this
expectation, the variants replace wild-type HBV in pa-
tients only to a certain extent and data on viremia (Wakita
et al., 1991; Gu¨nther et al., 1996a; Tsubota et al., 1998) do
not indicate a simultaneous decrease in virus replication,
both of which argue for an equilibrium between accumu-
lation of variants and virus production in vivo. Further-
more, it is a specific feature of C gene deletion variants
that they accumulate under immunosuppression
(Gu¨nther et al., 1996a) and disappear when the immune
response is activated on cessation of immunosuppres-
eny DNA produced after cotransfection of variant or control with WT-b
.2-kb single-stranded (ss) fragment. The positions of these fragments
ifferent positions due to variation of salt concentrations in individual
tant (dashed line) produced after cotransfection of variant with WT-b.
d versus the percentage of variant in the transfected DNA mixture. Top:
standard deviation; 20% variant, n 5 3; 50% variant, n 5 1; 66% variant,
by variant and WT-b, calculated with the level of overall progeny DNAd prog
nd a 3
es at d
uperna
plotte
an and
onatelyethods. (C) Level of progeny DNA produced proportionately by variant
bars, cytoplasm; shaded bars, supernatant).
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296 GU¨NTHER ET AL.sive treatment or seroconversion to anti-HBe (Gu¨nther et
al., 1996a; Marinos et al., 1996). This points to the im-
une response to counteract or prevent accumulation of
hese variants. According to the variant-wild-type co-
ransfection data, accumulation of deletion variants in
he nucleus may result in increased progeny DNA syn-
hesis. If this is accompanied by an increase of the ccc
NA pool and viral protein synthesis, these cells could
e more susceptible to T cell or cytokine-mediated kill-
ng. This scenario would be consistent with the severe
iver disease—up to hepatic failure—that is seen in
ome patients infected with C gene deletion variants
Uchida et al., 1994; Gu¨nther et al., 1996a; Marinos et al.,
996; Zoulim et al., 1996).
In conclusion, this study demonstrates that HBV with
eletions in the C gene has the capacity for enhanced
eplication which determines its interaction with wild-
ype HBV and has implications for selection, immune
ecognition, and virulence of these variants.
MATERIALS AND METHODS
atients
Patients I, D, and G were renal transplant recipients
nder long-term immunosuppression (Gu¨nther et al.,
1996a). Patient D selected C gene deletion variants 1
year before he died from end-stage liver disease; patient
G was infected by C gene deletion variants while the
liver disease decompensated; and patient I with chronic
hepatitis lost C gene deletion variants upon cessation of
immunosuppressive treatment and had no worsening of
liver disease. Serum samples of patient I were taken at
the beginning of follow-up and those of patients D and G
at the end of follow-up. Patient FT was an immunocom-
petent patient with chronic active hepatitis infected with
C gene deletion variants (Marinos et al., 1996). All pa-
tients were positive for HBsAg and HBeAg.
Construction of plasmids
Serum HBV DNA was purified by proteinase K diges-
tion and phenol–chloroform extraction. The C gene was
amplified for 30 cycles with Taq polymerase and primers
17671 (positions 1767–1788 starting from the EcoRI site,
TTTGTACTAGGAGGCTGTAGGC) and 25102 (2510–2487,
AGGTACAGTAGAAGAATAAAGCCC), cloned into vector
pCR II (Invitrogen, Leek, The Netherlands), and se-
quenced. Representative C gene fragments with dele-
tions were exchanged with the corresponding C gene
fragment of a monomeric HBV wild-type genome (Gali-
bert et al., 1979) integrated in plasmid pHBV-SapI (re-
erred to as WT-b). For subcloning, C gene fragments
ith deletions of 90, 24, or 120 nucleotides, derived from
atients I, D, and G, respectively, were amplified for 15
ycles with Pwo polymerase (Boehringer Mannheim,Mannheim, Germany), 0.5 mg plasmid DNA template,
nd 1 mM primer 18211 (1821–1841, CCGGAAAGCTT-
GAGCTCTTCTTTTTCACCTCTGCCTAATCA, HindIII site
for cloning underlined) and primer 23532 (2353–2314,
CGTCTAACAACAGTAGTCTCCGGAAGTGTTGATAGG-
ATA, BspEI site for cloning underlined). A C gene with a
deletion of 144 nucleotides, derived from patient FT, was
amplified using primers 18211 and 24282 (2428–2405,
GATCTTCTGCGACGCGGCGATTG, BsaBI half-site un-
derlined). The PCR products amplified with primers
18211 and 23532 were cleaved at the BspEI site of primer
23532 and were cloned into SmaI–BspEI-digested pHBV-
SapI, resulting in hybrid HBV genomes DC-90, DC-24,
and DC-120. A wild-type hybrid genome (WT-a) with a C
gene of genotype A, as well as a control genome (WT-
core2) with a C gene of genotype A that is defective due
o a nucleotide deletion, were constructed similarly. The
CR products amplified with primers 18211 and 24282
were cleaved at the HindIII site of primer 18211 and were
loned into HindIII–BsaBI-digested pHBV-SapI, resulting
n hybrid genome DC-144. Genome DC-144pol2 is iden-
tical to DC-144, but contains a nucleotide deletion cre-
ated artificially at the BsaBI cloning site. This leads to a
frame shift in the P gene and renders the hybrid genome
defective in polymerase expression. Correct insertion
and sequence of the C gene in the resulting hybrid
genomes was ascertained by sequencing. Plasmid
pCMV core contains the genotype D wild-type core pro-
tein sequence (Galibert et al., 1979) under control of the
CMV promoter (kindly provided by H. Schaller, Heidel-
berg).
Transfection of HBV DNA
Plasmids were prepared by the Qiagen procedure
(Qiagen, Hilden, Germany) and additionally purified with
RNase A and proteinase K (Boehringer Mannheim) to
remove traces of contaminating RNA and protein. Linear
HBV monomers with SapI-sticky ends were released
from pHBV-SapI and its derivatives by cleavage with 1.5
U SapI/mg DNA (New England Biolabs) for 12 h. Without
urther purification, 3 to 5 mg cleaved DNA [which is in
the linear range of the dose–response curve (Gu¨nther et
al., 1995)] were transfected alone or mixed with 2 to 4 mg
pCMV core according to the calcium phosphate precip-
itation method. HuH7 cells were plated at a density of
1.2 3 106 cells per 50-mm-diameter petri dish. Medium
was changed 1 day after transfection, and cells were
harvested 2–3 days later. Transfection efficiency was
measured by cotransfection of 1 mg of reporter plasmid
expressing secreted alkaline phosphatase (SEAP) and
determination of SEAP enzymatic activity in the cell cul-
ture supernatant. SEAP activity was similar for all vari-
ants. HBsAg and HBeAg in the medium were assayed
using commercially available kits (AxSYM, Abbott).
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297HBV C GENE DELETION VARIANTSPurification of HBV DNA from intracellular and
extracellular core particles
Cells were washed with ice-cold phosphate-buffered
saline (PBS) and lysed in 1 ml lysis buffer (50 mM
Tris–HCl [pH 7.4], 1 mM EDTA, 1% NP-40) per 50-mm-
diameter petri dish. The lysed cells were vortexed and
allowed to stand on ice for 15 min. Nuclei were pelleted
by centrifugation for 1 min at 14 krpm in a tabletop
centrifuge (Eppendorf 5415C). A fraction (25–50%) of the
supernatant was adjusted to 10 mM MgCl2 and treated
ith 100 mg DNaseI/ml for 30 min at 37°C. The reaction
as stopped by adding EDTA to a final concentration of
5 mM. Proteins were digested with 0.5 mg of proteinase
per ml–1% SDS for 2 h at 37°C. Nucleic acids were
urified by phenol–chloroform (1:1) extraction and etha-
ol precipitation.
The cell culture medium was clarified by centrifugation
t 8 krpm for 30 min (Sorvall SS-34 rotor). Four milliliters
f medium was layered on top of a 1-ml 20% sucrose
ushion in 10 mM Tris–HCl (pH 7.4)–1 mM EDTA–100 mM
aCl and centrifuged at 45 krpm for 4 h (Beckmann
W50.1 rotor). The pellet was resuspended in 500 ml of
0 mM Tris–HCl (pH 8.0) and treated as described above
or the isolation of HBV DNA from cytoplasmic core
articles.
urification of ccc HBV DNA from nuclei by alkaline
ysis
Pelleted nuclei were resuspended in 100 ml of solution
(50 mM glucose, 25 mM Tris/HCl [pH 8.0], 10 mM
DTA), mixed with 200 ml of solution II (0.2 N NaOH, 1%
SDS), and incubated for 5 min at room temperature. After
the addition of 150 ml of solution III (3 M K acetate, 11.5%
cetic acid) and incubation for 10 min on ice, nuclear
ebris were pelleted at 14 krpm in a tabletop centrifuge.
ucleic acids in the supernatant were purified by phe-
ol–chloroform (1:1) extraction and ethanol precipitation.
reparation of total RNA
Cells were washed twice with ice-cold PBS and lysed
n 5 ml of guanidinium lysis buffer (2 M guanidinium
hiozyanate, 12 mM Na citrate, 0.2 M Na acetate, 50%
vol/vol] phenol [water-saturated], 0.4% [vol/vol] b-mer-
captoethanol) per 50-mm-diameter petri dish. After the
addition of 500 ml of chloroform and 15 min of incubation
n ice, the lysates were centrifuged for 20 min at 11.5
rpm (Sorvall SS-34 rotor). The RNA in the aqueous
hase was precipitated with isopropanol, pelleted by
entrifugation, washed with ethanol, and dissolved in
ater.
outhern and Northern (RNA) blot analysisDNAs isolated from viral particles were separated on
1.5% agarose gel and 20 mg of total RNA was analyzedin a 1.5% agarose–formaldehyde gel. Nucleic acids were
blotted onto Hybond N nylon membranes (Amersham)
and hybridized with 32P-labeled fragments synthesized
ith full-length HBV DNA or b-actin cDNA as a control.
he probe was generated using a random-primed label-
ng kit (Amersham). Autoradiography was analyzed with
UJIX BAS 2000 (Fuji, Tokyo, Japan).
mmunoblot analysis
Cells were washed with ice-cold PBS, collected in 1 ml
f PBS, and pelleted at 2 krpm in a tabletop centrifuge.
he cell pellet was lysed in 5 vol of SDS loading buffer,
oiled for 5 min, sonicated, and centrifuged. For detec-
ion of core protein, total cell lysate was separated in an
DS–17.5% polyacrylamide gel. The proteins were trans-
erred in Towbin buffer to a polyvinylidene difluoride
embrane (Bio-Rad, Hercules, CA) and detected using
olyclonal rabbit anti-HBc-83 (Bichko et al., 1993) (dilu-
ion 1:5000). After separation of the cell lysate in a 10%
el and blotting to nitrocellulose membrane (Schleicher
Schuell, Germany), HBV polymerase and pre-S1/2 pro-
eins were detected using monoclonal antibodies anti-
ol 3.12F (unpublished) (diluted 1:10) and a mixture of
nti-pre-S2 2F12 and 1-9D1 (each diluted 1:40; kindly
rovided by W. Gerlich, Gießen, Germany), respectively.
or protein detection, three rounds of incubation with
rimary and secondary antibody were performed before
etection by chemiluminescence. The image was digi-
ized using a scanner.
FLP assay to measure enrichment of variants
Following cotransfection of variant genomes with WT-b,
BV DNA was isolated from nuclei as well as from intra-
nd extracellular particles and amplified with the Expand
igh fidelity PCR assay (Boehringer Mannheim) and 0.2 mM
primers 16451 (1645–1669, IRD-labeled-AGGTCTTACATAA-
AGGACTCTGGG) and 19772 (1977–1952, CGGTCCAGC-
CCGGCGTCGACGAAGGAAAGAAGTCAGAAGGCAAAAA,
TaqI site for cleavage control underlined). The PCR was run
for 40 cycles with 1 min at 94°C, 1.5 min at 55°C, and 1.5
min at 72°C in a Robocycler (Stratagene). The PCR prod-
ucts were purified (QIAquick PCR purification kit, Qiagen)
and 10% thereof were digested with 10 U TaqI in a 10-ml
assay. An aliquot was denatured and resolved in a 5%
polyacrylamide–7 M urea gel on an automated sequencer
(LI-COR, Lincoln, NE). Separated restriction fragments were
detected and quantified via the fluorescence-dye-labeled
primer and enrichment was calculated as follows: enrich-
ment factor 5 (signal of variant in cytoplasm or superna-
tant 3 signal of WT-b in nucleus)/(signal of variant in nu-
cleus 3 signal of WT-b in cytoplasm or supernatant).
CalculationsThe level of progeny variant and progeny WT-b DNA
(PDC and PWT-b) produced proportionately following co-
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298 GU¨NTHER ET AL.transfection of both virus DNAs was calculated with the
percentage of variant and WT-b DNA in the transfection
mixture (TDC and TWT-b, respectively; both sum up to 1.0
[100%]), the corresponding, experimentally determined
level of total progeny DNA (P total), and the corresponding,
xperimentally determined enrichment factor (f). The ra-
io of progeny variant to progeny WT-b DNA is described
y the equation PDC/PWT-b 5 fTDC/TWT-b, and the sum of
progeny variant and progeny WT-b DNA is described by
the equation PWT-b 1 PDC 5 P total. Both equations were
combined to determine the level of progeny DNA of
variant and WT-b: PDC 5 P total/(1 1 TWT-b/TDCf ) and PWT-b 5
total/(1 1 fTDC/TWT-b). The level of progeny DNA in relation
to the corresponding amount of transfected DNA was
calculated as PDC/TDC and PWT-b/TWT-b.
mage processing and quantitative data evaluation
Digitized autoradiography, chemiluminescence, and
luorescence signals were quantified using TINA soft-
are (Raytest, Straubenhardt, Germany). For presenta-
ion, brightness and contrast of the images were ad-
usted with Corel Photo Paint software (Corel Corpora-
ion, Ottawa, Canada).
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